Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Ophthalmology. 2016 Oct 18;123(12):2462–2473. doi: 10.1016/j.ophtha.2016.09.003

Cataract Surgery in Children from Birth to Less than 13 Years of Age: Baseline Characteristics of the Cohort

Michael X Repka 1, Trevano W Dean 2, Elizabeth L Lazar 2, Kimberly G Yen 3, Phoebe D Lenhart 4, Sharon F Freedman 5, Denise Hug 6, Bahram Rahmani 7, Serena X Wang 8, Raymond T Kraker 2, David K Wallace 5
PMCID: PMC5121052  NIHMSID: NIHMS816073  PMID: 27769584

Abstract

Objective

To describe baseline characteristics, initial postoperative refractive errors, operative complications, and magnitude of the intraocular lens (IOL) prediction error for refractive outcome in children undergoing lensectomy largely in North America.

Design

Prospective, registry study of children from birth to <13 years of age having undergone lensectomy for any reason within 45 days preceding enrollment.

Participants

1,266 eyes of 994 children; 49% female and 59% white

Testing

Measurement of refractive error, axial length, and complete ophthalmic examination

Main Outcome Measures

Eye and systemic associated conditions, IOL style, refractive error, pseudophakic refraction prediction error, operative and perioperative complications

Results

Mean age at first eligible lens surgery was 4.2 years; 337 (34%) from birth to <1 year of age. Unilateral surgery was performed in 584 (59%) children. Additional ocular abnormalities were noted in 301 (24%) eyes. An IOL was placed in 35 of 460 (8%) eyes when surgery was performed prior to 1 year of age, in 70 of 90 (78%) eyes from 1 to <2 years of age, and in 645 of 716 eyes (90%) from 2 to <13 years of age. The odds of IOL implantation were greater in children ≥2 years of age than those <2 years of age (odds ratio=29.1; p<0.001; 95% confidence interval: 19.6 to 43.3). Intraoperative complications were reported for 69 (5%) eyes, with the most common being unplanned posterior capsule rupture in 14 eyes, 10 of which had an IOL placed. Prediction error of the implanted IOL was <1.00 D in 54% of eyes, but >2.00 D in 15% of eyes.

Conclusions

Lensectomy surgery was performed throughout childhood, with about two-thirds of cases performed after one year of age. Initial surgery appeared safe with a low complication rate. IOL placement was nearly universal in children 2 years of age and older. The immediate postoperative refraction was within 1 diopter of the target for about one-half of eyes.

Precis

Children <13 years of age undergoing lensectomy, rarely had a medical abnormality known to be associated with cataract; however, one in five had a positive family history of early cataract. Intraocular lenses were used in nearly all children after two years of age.

Introduction

Childhood cataract in the developed world is an uncommon, but important, cause of lifelong visual impairment. The prevalence of visually significant infantile cataract has been estimated to range from 3.0 to 4.5 per 10,000 live births, affecting up to 2000 infants annually in the United States.1 These are about equally divided between bilateral and unilateral cases. There are limited data on the prevalence of acquired cataracts during childhood in the US.

Most children in developed countries with visually significant cataract(s) undergo surgery. A number of ophthalmic sequelae may occur including secondary opacification of the visual axis, contraction of the capsular openings, lens cellular Elschnig pearl formation, amblyopia, glaucoma, ametropia, anisometropia, strabismus, retinal detachment, additional ocular surgery, and failure of the operated eye to emmetropize. The incidence, natural history and risk factors for each of these adverse events as well as the impact on visual acuity have not been prospectively studied in a large cohort. The authors of a systematic review2 of surgical interventions for bilateral congenital cataract recognized the need for ongoing research to identify risk factors, particularly for secondary glaucoma and retinal detachment. Few clinical trials have evaluated the management of childhood cataract and most information on clinical outcomes is based upon case series, with two notable exceptions.35

The Pediatric Eye Disease Investigator Group (PEDIG) developed a cataract surgery registry to collect data on children undergoing lensectomy for any reason from birth to < 13 years of age with 5 years of follow-up. There were two primary objectives for development of this registry: 1) to determine the occurrence and risk factors for complications following cataract surgery after a minimum of 5 years in a cohort of about 1000 children, and 2) to provide visual acuity outcome data for unilateral and bilateral cataract surgery, with and without IOL implantation.

Herein we describe the baseline characteristics of 994 children birth to < 13 years of age who underwent lensectomy largely in North America. In addition, we describe initial postoperative refractive errors, operative complications, and magnitude of the prediction error for refractive outcome in children receiving IOLs.

Methods

This study, supported through a cooperative agreement with the National Eye Institute of the National Institutes of Health, was conducted by PEDIG. An Investigational Device Exemption (#G110149) was obtained from the United States Food and Drug Administration, Centers for Devices and Radiologic Health, Silver Spring, Maryland because of the use a medical device for an unapproved indication. The protocol and HIPAA-compliant informed consent forms were approved by each participating site’s institutional review board. The parent or guardian of each child gave written informed consent.

Between June 2012 and July 2015, 61 centers (3 in Canada, 57 in the US, and 1 in the UK) enrolled children from birth to <13 years of age who had undergone lensectomy for any reason during the preceding 45 days into a clinical research registry. Surgery was performed prior to consent and enrollment. Ophthalmic, systemic and historical data were collected for each child at the time of enrollment from medical record review. Data from fellow eyes that had cataract surgery within one year following enrollment are included in this report. Bilateral cases were defined by performance of surgery in both eyes within one year after enrollment or by report of lensectomy in the fellow eye prior to enrollment.

Logistic regression with generalized estimating equations to adjust for inter-eye correlation was used to 1) estimate the odds of IOL implantation in children undergoing bilateral lensectomy compared with children undergoing unilateral lensectomy, 2) estimate the odds of IOL implantation in children ≥2 years of age compared with children <2 years of age adjusting for laterality of surgery, and 3) compare the odds of IOL implantation between children undergoing unilateral surgery and those undergoing bilateral surgery separately in children <2 years of age and in those ≥2 years of age.

Descriptive statistics were calculated for postoperative spherical equivalent refractive error, measured 1 to 45 days after surgery, stratified by IOL placement; and for axial length, stratified by laterality of lens surgery and age group. The IOL prediction error was calculated as the difference between the target refractive error and the postoperative spherical equivalent refractive error. The absolute value of the prediction error was determined and descriptive statistics calculated.

Results

The PEDIG registry included 1,266 eyes of 994 children undergoing a lensectomy (Table 1): 69 children in Canada, 914 children in the US, and 11 in the UK. Forty-nine percent were female; 59% were white. Unilateral surgery was performed in 584 (59%) children. Bilateral surgery was performed in 410 (41%) children (141 of 410 had undergone lensectomy in one of their eyes more than 45 days prior to study enrollment and those eyes were not included in these analyses).

Table 1.

Baseline Characteristics of Enrolled Children (N=994)

N (%)
Enrolled Patients 994 (100)
Sex
  Female 490 (49)
  Male 504 (51)
  Laterality of Surgery
  Bilateral 410 (41)
  Unilaterala 584 (59)
Age at First Eligible Surgeryb
  <6 months 269 (27)
  6 months to <1 year 68 (7)
  1 to <2 years 72 (7)
  2 to <4 years 122 (12)
  4 to <7 years 211 (21)
  7 to <13 years 252 (25)
  Mean (SD) years 4.17 (3.84)
  Median (Range) years 3.60
(0.04 to 12.98)
Race/Ethnicity
  American Indian/Alaska 5 (<1)
  Asian 36 (4)
  Black/African American 145 (15)
  Hispanic 160 (16)
  White 582 (59)
  More than one race 42 (4)
  Unknown/not reported 24 (2)
a

Two patients had bilateral cataracts, but one eye was considered too abnormal for surgery.

b

Patients who underwent surgery in both eyes may contribute 2 eyes to the study. Age at first eligible surgery refers to the child’s age when surgery was performed on the first enrolled eye.

SD - standard deviation

Mean age at first eligible surgery was 4.2 ± 3.8 years (median=3.6 years, interquartile range=5 months to 7.1 years). Seventy-three percent of children were of normal birth weight (>2500 g) and 80% of normal post-menstrual age (37 to 42 weeks) (Table 2a). Additional characteristics are provided in Tables 2a and 2b. Table 3 lists ocular conditions other than an abnormal crystalline lens found in the enrolled eyes prior to surgery; an ocular abnormality was present in 301 (24%) of 1266 enrolled eyes. Persistent fetal vasculature was reported for 63 (5%) eyes. Trauma was the cause of cataract in 86 eyes.

Table 2.

a Medical History of Enrolled Children at Baseline Stratified by Laterality of Surgery (N=994)

Laterality of Surgery
Bilateral Unilateral Overall
N (%) N (%) N (%)
Enrolled Patients 410 (100) 584 (100) 994 (100)
Current Medical Conditions
  Yes 163 (40) 153 (26) 316 (32)
  No 245 (60) 430 (74) 675 (68)
  Unknown 2 (<1) 1 (<1) 3 (<1)
Medical Conditions Reported
  Attention deficit
hyperactivity disorder
3 (<1) 8 (1) 11 (1)
  Antenatal infection 3 (<1) 0 (0) 3 (<1)
  Asthma 14 (3) 14 (2) 28 (3)
  Congenital Malformations 2 (<1) 5 (<1) 7 (<1)
  Diabetes 3 (<1) 1 (<1) 4 (<1)
  Developmental delay 35 (9) 14 (2) 49 (5)
  Down Syndrome 20 (5) 11 (2) 31 (3)
  Galactosemia 0 (0) 0 (0) 0 (0)
  Genetic 17 (4) 14 (2) 31 (3)
  Heart/Cardiac 15 (4) 5 (<1) 20 (2)
  Leukemia 4 (<1) 5 (<1) 9 (<1)
  JIA 5 (1) 10 (2) 15 (2)
  Marfan syndrome 9 (2) 3 (<1) 12 (1)
  Prematurity 3 (<1) 1 (<1) 4 (<1)
  Psychiatric/Neurological 16 (4) 8 (1) 24 (2)
  Skin 3 (<1) 3 (<1) 6 (<1)
  Tumor 4 (<1) 9 (2) 13 (1)
  Other 39 (10) 30 (5) 69 (7)
b Medical, Family, and Social History of Enrolled Children at Baseline (N=994)

N (%)
Currently Using Systemic Medications
  Yes 160 (16)
  No 826 (83)
  Unknown 8 (<1)
Systemic Medications Currently Being Used
  Attention deficit hyperactivity disorder 10 (1)
  Asthma 31 (3)
  Diamox 4 (<1)
  Insulin 4 (<1)
  Methotrexate 24 (2)
  Seizure 8 (<1)
  Oral Steroids 42 (4)
  Other (eg, cold, vitamins, analgesics) 130 (13)
Current or Prior Use of Steroids 73 (7)
Family History of Infantile of Juvenile Cataracts
  Yes 179 (18)
  No 775 (78)
  Unknown 40 (4)
Birth Weight
  <=1500 grams 34 (3)
  >1500 to 2000 grams 18 (2)
  >2000 to 2500 grams 65 (7)
  >2500 to 4000 grams 644 (65)
  >4000 grams 79 (8)
  Unknown 154 (15)
  Mean (SD) grams 3173 (750)
  Median (Range) grams 3260
(425 to 5103)
Post-menstrual Age at Birth
  <32 weeks 32 (3)
  32 to <37 weeks 77 (8)
  37 to <42 weeks 797 (80)
  >= 42 weeks 15 (2)
  Unknown 73 (7)
  Mean (SD) weeks 38.6 (3.0)
  Median (Range) weeks 40.0
(22.0 to 44.0)
Household Size
  <=4 persons 619 (62)
  >4 persons 302 (30)
  Unknown 73 (7)
Parent Education Level
  <High School 35 (4)
  >=High School/GED 803 (81)
  Unknown 156 (16)
Primary Healthcare Coverage
  None 5 (<1)
  Unknown 16 (2)
  Employer Provided Health Insurance 327 (33)
  Medicaid/State CHIP 437 (44)
  Military 19 (2)
  Private Health Insurance 121 (12)
  Government, non-United States 69 (7)

SD - standard deviation. GED – successful completion of a general education development test. CHIP – Children’s Health Insurance Program

Table 3.

Ocular Conditions Reported at Baseline

N (%)
Eye-Level Conditions (N=1266)
Glaucoma
  Yes 79 (6)
  No 1187 (94)
Pre-operative Eye Abnormalities
  Yes 301 (24)
  No 951 (75)
  Unknown 14 (1)
Pre-operative Eye Abnormalities
  Anterior and Posterior
Segments
56 (4)
  Anterior Segment Only 156 (12)
  Posterior Segment Only 89 (7)
  None 951 (75)
  Unknown 14 (1)
Patient-Level Conditions (N=994)
Uveitis 28 (3)
Strabismus
  Yes 222 (22)
  No 727 (73)
  Unknown 45 (5)

Axial length, reported for 373 (64%) unilateral and 419 (62%) bilateral surgical eyes, was not different between unilateral and bilateral cases when assessed by age (Table 4). Axial length increased with age, ranging from 17.3 mm in eyes of children <3 months of age to 23.0 mm in children 7 to <13 years of age (Figure 1).

Table 4.

Distribution of Axial Length (mm) Stratified by Laterality of Cataract Surgery and Age at Surgery

Bilateral
(N=419)
Unilateral
(N=373)
<3 Months N 61 39
Mean (SD) 17.2 (1.9) 17.4 (1.3)
Median (Range) 16.7
(13.7 to 21.8)
17.5
(14.8 to 20.6)
3 to <6 Months N 34 9
Mean (SD) 18.9 (1.1) 19.5 (1.9)
Median (Range) 19.0
(16.2 to 21.1)
19.0
(17.1 to 23.8)
6 to <12 Months N 15 27
Mean (SD) 20.2 (1.2) 20.4 (2.3)
Median (Range) 20.7
(17.5 to 21.2)
20.0
(16.6 to 28.8)
1 to <4 Years N 109 88
Mean (SD) 22.0 (1.6) 21.9 (1.9)
Median (Range) 22.1
(17.4 to 26.2)
21.5
(18.7 to 28.4)
4 to <7 Years N 100 92
Mean (SD) 21.9 (1.6) 22.5 (1.9)
Median (Range) 21.8
(18.7 to 28.2)
22.3
(12.4 to 28.1)
7 to <13 Years N 100 118
Mean (SD) 23.0 (1.8) 23.0 (1.7)
Median (Range) 22.9
(18.3 to 31.4)
22.8
(17.6 to 31.1)

SD – Standard deviation

Figure 1.

Figure 1

Distribution of Axial Length for Bilateral and Unilateral Cataract Surgery Stratified by Age at Surgery. Axial length increased with age, regardless of laterality of cataract surgery. The top and bottom of each box represents the 75th and 25th percentiles of the data, respectively. Group medians are represented by the horizontal line in each box and group means by filled circles. The bars extending above and below each box represent 1.5 times the interquartile range (difference between the 75th and 25th percentiles), or the maximum (or minimum) observed value within the range if not as extreme as the calculated value. The open circles represent statistical outliers.

An IOL was placed in 59% of all eyes in the study; in 35 of 460 (8%) when surgery was performed prior to 1 year of age, in 70 of 90 (78%) children from 1 to <2 years of age, and in 645 of 716 (90%) children from 2 to <13 years of age. The odds of IOL implantation were greater in children ≥2 years of age than those <2 years of age (odds ratio (OR)=29.1; p<0.001; 95% CI=19.6 to 43.3) and were lower in children undergoing bilateral surgery compared with unilateral surgery (OR=0.74; p=0.02; 95% CI=0.57 to 0.96). In children <2 years of age, the odds of IOL implantation were lower in children undergoing bilateral surgery compared with those undergoing unilateral surgery (OR=0.58; p=0.03; 95% CI=0.35 to 0.95), however there did not appear to be a difference in children ≥2 years of age (OR=0.92; p=0.77; 95% CI=0.53 to 1.59). With unilateral lens surgery, IOL implantation increased from <1% when <3 months of age to 90% when 7 to <13 years of age (Figure 2). With bilateral lens surgery, IOL implantation increased from 3% when younger than three months to 91% when 7 to <13 years of age (Figure 2, Figure 3). Of the 71 eyes left aphakic after 2 years of age, 13 (18%) were related to traumatic cataract.

Figure 2.

Figure 2

Intraocular Lens (IOL) Implantation for Children with Unilateral Cataract Surgery Stratified by Age at Surgery. The percentage of IOL implantation increased with age in children undergoing unilateral surgery. Each column displays the number of eyes with cataract surgery within each age group. Columns are divided into two categories, representing the percentage of eyes within that age group that received IOL implant at the time of surgery (light grey) and those that did not (dark grey).

Figure 3.

Figure 3

Intraocular Lens (IOL) Implantation for Children with Bilateral Cataract Surgery Stratified by Age at Surgery. The percentage of IOL implantation increased with age in children undergoing bilateral surgery. Each column displays the number of eyes with cataract surgery within each age group. Columns are divided into two categories, representing the percentage of eyes within that age group that received an IOL implant at the time of surgery (light grey) and those that did not (dark grey).

The most common implant was a foldable acrylic lens from a variety of manufacturers (Table 5). The implant was placed in the posterior chamber in 715 (95%) of 750 eyes. Fixation was reported in the capsular bag for 85% of eyes and in the ciliary sulcus for 14% of eyes. For eyes receiving an IOL, management of the posterior capsule included no capsulotomy in 34%, a limbus approach capsulotomy in 43%, and a pars plana/plicata approach in 19% (Table 6). A trend to preservation of the posterior capsule with increasing age was seen, with no capsulotomy performed in 55% of eyes of children after 7 years of age. Anterior vitrectomy was performed in 59% of eyes receiving an IOL. The IOL power ranged from +2.00D to +39.00D, with most IOLs between +20.00D and +26.00D (Figure 4).

Table 5.

Intraocular Lens (IOL) Implantation

N (%)
Total Eyes 1266 (100)
IOL Implanted
  Yes 750 (59)
  No 516 (41)
IOL Brand – Model (N=750 Eyes)
  Alcon Acrysof – 1-piece and 3-piece 684 (91)
  Bausch and Lomb Sofport AO 25 (3)
  Abbott Medical Optics Technis 17 (2)
  Rayner 4 (<1)
  Staar Surgical Company CQ2015 1 (<1)

Table 6.

Distribution of Capsulotomy Stratified by Intraocular Lens (IOL) Implantation

IOL Implanted
(N=750)
No IOL Implanted
(N=516)
N (%) N (%)
Primary capsulotomy
  None 257 (34) 42 (8)
  Limbus approach 322 (43) 399 (77)
  Pars plana/plicata approach 146 (19) 42 (8)
  Other 11 (1) 11 (2)
  Unknown 14 (2) 22 (4)

Figure 4.

Figure 4

Distribution of Power of Implanted Intraocular Lenses (IOL). IOL power, ranging from +2.00 to +39.00 diopters, was reported for 744 eyes.

Intraoperative complications were reported for 69 (5%) eyes. The most common complication was an unplanned posterior capsule rupture in 10 (1%) of 750 eyes having primary IOL placement (Table 7). Complication rates did not differ between eyes receiving a primary IOL (pseudophakic eyes) and eyes without an IOL (aphakic eyes). Postoperative complications between 1 and 45 days after surgery were reported for 197 (16%) of 1266 eyes: 14% with pseudophakia and 17% with aphakia. Acute elevation of intraocular pressure and cloudy cornea were the most prevalent, each reported for 2% of eyes.

Table 7.

Ocular Complications Stratified by Intraocular Lens (IOL) Implantation Status

IOL
Implanted
(N=750)
No IOL
Implanted
(N=516)
All Eyes
(N=1266)
N (%) N (%) N (%)
Operative Complications (day of surgery)
  Yes 40 (5) 29 (6) 69 (5)
  No 710 (95) 487 (94) 1197 (95)
Reported Operative Complications
  Cloudy cornea 1 (<1) 2 (<1) 3 (<1)
  Hyphema 3 (<1) 1 (<1) 4 (<1)
  Iris damage 2 (<1) 4 (<1) 6 (<1)
  Iris prolapsed 6 (<1) 0 (0) 6 (<1)
  Iris sphincterotomy 2 (<1) 1 (<1) 3 (<1)
  Lens fragment in vitreous 1 (<1) 2 (<1) 3 (<1)
  Retained cortex 3 (<1) 2 (<1) 5 (<1)
  Ruptured posterior capsule 10 (1) 4 (<1) 14 (1)
Unplanned iridectomy 0 (0) 3 (<1) 3 (<1)
  Other 19 (3) 13 (3) 32 (3)
Postoperative Complications (Post-op days 1 to 45)
  Yes 107 (14) 90 (17) 197 (16)
  No 643 (86) 426 (83) 1069 (84)
Reported Postoperative Complications
  Acute ocular hypertension 15 (2) 8 (2) 23 (2)
  Cloudy cornea 8 (1) 11 (2) 19 (2)
  Dislocated implant 1 (<1) 0 (0) 1 (<1)
  Endophthalmitis 0 (0) 0 (0) 0 (0)
  Hyphema 2 (<1) 3 (<1) 5 (<1)
  Iris damage 11 (1) 6 (1) 17 (1)
  Iris prolapsed 1 (<1) 0 (0) 1 (<1)
  Iris sphincterotomy 0 (0) 0 (0) 0 (0)
  Lens fragment in vitreous 0 (0) 2 (<1) 2 (<1)
  Retained cortex 4 (<1) 2 (<1) 6 (<1)
  Return to operating room within 1 week 3 (<1) 1 (<1) 4 (<1)
  Ruptured posterior capsule 0 (0) 0 (0) 0 (0)
  Unplanned iridectomy 0 (0) 0 (0) 0 (0)
  Other 79 (11) 79 (15) 158 (12)

Immediate postoperative refractive errors were determined within 45 days of surgery (Figures 5, 6). The mean spherical equivalent refraction was +1.36 diopters (D) (SD = 2.37, median = +1.13 D, range = −10.00 D to +14.50 D) among pseudophakic eyes and +17.65 D (SD = 7.80, median = +19.00 D, range = −12.00 D to +35.00 D) among aphakic eyes. As evident in Figures 5 and 6, a wide range of postoperative spherical equivalent refractive errors were reported, with a few outliers responsible for the large ranges. Ninety percent of pseudophakic eyes were between −2.00 D and +5.25 D, while 90% of aphakic eyes were between 0.00 D and +29.00 D.

Figure 5.

Figure 5

Distribution of Postoperative Refractive Error in Pseudophakic Eyes. Postoperative refractive error reported for 651 eyes with a mean of +1.36 D (range = −10.00 D to +14.50 D).

Figure 6.

Figure 6

Distribution of Postoperative Refractive Error in Aphakic Eyes. Postoperative refractive error reported for 416 eyes with a mean of +17.65 D (range = −12.00 D to +35.00 D).

The IOL calculation formulae were chosen by each investigator. For 92% of pseudophakic eyes, a target refractive error was reported. On average, low hyperopia was the target for the immediate postoperative refractive error (mean = +1.45 D, SD = 1.88, median = +1.00 D, range = −8.50 D to +8.00 D; Figure 7). More hyperopia was planned for younger children, with a mean of +4.52 D for children 6 months to <1 year of age and +0.32 D for children 7 to <13 years of age (Figure 8).

Figure 7.

Figure 7

Distribution of Target Refractive Error in Pseudophakic Eyes. The target refractive error varied from −8.50 to +8.00 Diopters for 689 eyes with a reported target.

Figure 8.

Figure 8

Distribution of Target Refractive Error Stratified by Age at Surgery. Target refractive error, reported for 689 eyes, appeared to decrease with age; more hyperopia was planned for younger children. The top and bottom of each box represent the 75th and 25th percentiles of the data, respectively. Group medians are represented by the horizontal line in each box and group means by filled circles. The bars extending above and below each box represent 1.5 times the interquartile range (difference between the 75th and 25th percentiles), or the maximum (or minimum) observed value within the range if not as extreme as the calculated value. The open circles represent statistical outliers.

Of the 750 eyes receiving an IOL, there were sufficient data (target refraction and immediate postoperative refraction) to calculate the prediction error for 599 (80%) eyes (Figure 9). Prediction error was <1.00 D in 54% of eyes, but >2.00 D in 15% of eyes. The mean of the absolute value of the prediction error was 1.11 D ± 1.14 (median = 0.75 D, range = 0 to 9.13 D). Prediction error did not vary by laterality within subgroups of age at time of surgery (Figure 10 – Online only).

Figure 9.

Figure 9

Distribution of Prediction Error in Pseudophakic Eyes. Prediction error (Diopters) was calculated for 599 eyes for which there were both a target refractive error and a postoperative refractive error.

Analyses after exclusion of traumatic cataract surgery found glaucoma at baseline, postoperative ocular hypertension, and prediction error (Figure 11 – Online only) to be unchanged.

Discussion

We enrolled 994 children from birth to <13 years of age undergoing lensectomy in one or both eyes to participate in a prospective 5-year observational study of childhood lensectomy, greater than 99% performed for cataract. The race/ethnicity of our cohort is similar to that of the overall population of the United States in 2014,6 with nearly 40% of the children from minority groups. About one in four children had additional ocular abnormalities. Only one-third of children were younger than one year of age at time of their first eligible surgery. Lens surgery was performed throughout childhood up to 12 years of age.

There are two recent large prospective studies of childhood cataract surgery. IATS reported results of a randomized trial of 114 infants with unilateral infantile cataract with surgery between 1 month and 6 months of age with 5 years of follow up.3, 4 IATS included only children with a normal fellow eye and no major structural abnormalities in the operated eye. Median visual acuity at 5 years did not differ between the IOL and no IOL treatment groups, although additional surgery to clear the visual axis was more common in the IOL group.

The British Isles Congenital Cataract Interest Group (BCCIG) enrolled a prospective national inception cohort of 221 children younger than 2 years of age undergoing cataract surgery in the United Kingdom and Northern Ireland between January 2009 and December 2010.5 BCCIG investigators felt they had near complete ascertainment of eligible children birth to less than two years of age. Each of these studies will serve as important comparisons for subgroups in our future reports, although such comparisons will be limited by differences in the populations and years of recruitment.

In our study the presence of a medical condition known to be associated with early cataract or lens abnormality was rare; Down syndrome accounted for 3% and Marfan syndrome for 1%. There were no cases associated with galactosemia. More common was a family history of infantile cataract (18%). These data support the value of a thorough medical evaluation and family history. However, given the low incidence of associated medical conditions detected through standard of care clinical testing, reevaluation of the recommended testing suggested for bilateral cataracts, including assessments of galactose metabolism, infectious disease, and metabolic disorders, would seem warranted.7 It is possible that a thorough family history, pediatric medical history, assessment of medication use, and physical exam could eliminate the need for many of these tests.

While IOLs were implanted in 59% of all enrolled eyes, there was a significant effect of age on the decision to implant, with 8% of eyes implanted before 1 year of age and 90% of eyes implanted after 2 years of age. This finding demonstrates the continuing widespread use of IOLs in children in North America. A survey in 2001 of pediatric ophthalmologists found that between 1 and 2 years of age was the minimum age felt reasonable for implantation of an IOL.8 A survey of practice patterns from 2008–2009 in the UK and Ireland found most surgeons performed IOL implantation in children younger than 2 years of age, but 25% would not place an IOL in children younger than one year of age.9 However, the use of IOLs in children younger than one year of age may have been slowed during our recruitment period by publication of the 1- and 5-year IATS results,3, 4 which failed to demonstrate an advantage to implantation of IOLs in infants younger than 7 months of age and urged caution in their use. In the more recent cohort study in the UK and Ireland of actual surgical cases, BCCIG investigators reported on the surgery for 221 children younger than 2 years of age with 1 year of follow-up; they placed implants in 44% (40% of bilateral and 53% of unilateral cases).5 In the PEDIG registry, investigators implanted IOLs in only 19% of eyes in this same age range, suggesting a more cautious approach or differing referral patterns. In the present study, posterior capsulotomies were performed in most cases until about 7 years of age after which fewer than 50% of eyes had a primary capsulotomy performed. Presumably this was the time point when the majority of investigators assumed they could do an office-based laser capsulotomy if necessary.

The IOL calculation formula used was chosen and adjusted at the discretion of the surgeon along with the selection of the power of the particular IOL. While the range of chosen target refractive errors was large, the majority of cases were targeted to low hyperopia. As expected, more hyperopia was chosen at younger ages, while emmetropia was chosen for children 7 to <13 years of age (Figure 8). The mean power chosen between 6 months and 1 year of age by our investigators was +4.52 D, much less than the +6.00 D targeted for infants 6 weeks to 6 months of age in the IATS protocol.10 In addition, the targets our investigators chose for children <3 years of age were generally less hyperopic than the myopic shifts that would be anticipated from earlier studies of refractive error change after cataract surgery.11 This could mean that our registry participants may be more myopic than intended when reviewed in 5 years.

IOL power selection was fairly accurate with the absolute prediction error <1.00 D in 54%, but >2.00 D in 15%. Interestingly, the prediction error did not vary by age. In IATS the best prediction error when using the Holladay 1 formula was <1.00 D in 45%, but IATS included only infant eyes.12 While the IOL power accuracy is better in our study, we included older children, which should make precision of preoperative measurements easier and perhaps more precise. The long term significance of the early prediction error in IOL power selection is uncertain at this early stage, but longitudinal follow-up of refractive progression over 5 years will provide more information regarding the significance of choice of IOL power.

Intraoperative complications were reported in 5% of eyes with the most common being unplanned posterior capsular rupture in 1%. An additional 16% of eyes were reported to have an adverse event during the 45-day postoperative period, most commonly an episode of ocular hypertension in 2%, with no newly diagnosed cases of glaucoma. IATS reported an intraoperative complication rate of about 20% among infants, most commonly iris prolapse.13 BCCIG’s cohort of children under 2 years of age reported a perioperative complication rate of 10%, most commonly iris prolapse.5 Iris prolapse occurred at a much lower rate in the current study, which may again be due to our inclusion of older children.

There are several strengths to our study. This is a large, multicenter, prospective cohort study of 994 children undergoing lensectomy in a real-world setting (337 children were younger than one year of age) of a race/ethnicity distribution similar to that of the United States.6 The large sample size should help establish tighter confidence intervals on rates of important clinical outcomes such as glaucoma. The data collection forms we used forced clinicians to report key data elements such as complications and medical history, which should be relatively complete. This lens surgery registry also includes outcomes for high-risk patients (eg. glaucoma, retinopathy of prematurity, persistent fetal vasculature), often excluded in clinical trials or case series, thus making the results more generalizable. Each of these factors will allow use of these pooled registry data as benchmarks for an individual physician’s performance in the future.

There are limitations to our research registry. Although we recruited a large sample from an ethnically and socially diverse population, our study is not population-based. Furthermore, with the cohort limited mainly to North America, the data on associations with cataract reflects that of developed countries and would differ dramatically from the developing world. We did not have a specific protocol so there are missing data elements, but we did request specific data on the collection forms, which were completed at the time of surgery and the two immediate postoperative visits. This should reduce the potential for data collection inaccuracies compared with routine reporting from medical records, a concern previously expressed and studied by BCCIG.14 Children were managed at investigator discretion, so there is the potential for treatment bias at enrollment such as implanting an IOL in otherwise normal eyes undergoing uneventful surgery and using a contact lens or eyeglasses for other children.

In summary, lens surgery reported to the registry was performed throughout childhood, with about two-thirds of cases performed after one year of age. Initial surgery had a low complication rate in the 45 days following surgery. IOL placement was nearly universal in children >2 years of age. Future reports will focus on clinical outcomes after 5 years such as visual acuity, development of complications, and refractive error.

Supplementary Material

1
2
3

Acknowledgments

Funding/Support: Supported by National Eye Institute of National Institutes of Health, Department of Health and Human Services EY011751, EY023198, and EY018810. The funding organization had no role in the design or conduct of this research.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Meeting Presentation: Content from this manuscript was presented at the May 2014 annual meeting of Association for Research In Vision & Ophthalmology (ARVO) in Orlando, FL and at the March 2015 annual meeting of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) in New Orleans, LA.

This article contains online-only material. The following should appear online-only: Figure 10, Figure 11.

FDA Disclaimer: The study was conducted under an Investigational Device Exemption (#G110149) from the United States Food and Drug Administration.

Conflict of Interest: No conflicting relationships exist for any author.

References

  • 1.Holmes JM, Leske DA, Burke JP, Hodge DO. Birth prevalence of visually significant infantile cataract in a defined U.S. population. Ophthalmic Epidemiol. 2003;10(2):67–74. doi: 10.1076/opep.10.2.67.13894. [DOI] [PubMed] [Google Scholar]
  • 2.Long V, Chen S, Hatt S. Surgical interventions for bilateral congenital cataract. Cochrane Database Syst Rev. 2006;(3):CD003171. doi: 10.1002/14651858.CD003171.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Infant Aphakia Treatment Study Group. A randomized clinical trial comparing contact lens with intraocular lens correction of monocular aphakia during infancy: grating acuity and adverse events at age 1 year. Arch Ophthalmol. 2010;128(7):810–818. doi: 10.1001/archophthalmol.2010.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Infant Aphakia Treatment Study Group. Comparison of contact lens and intraocular lens correction of monocular aphakia during infancy: a randomized clinical trial of HOTV optotype acuity at age 4.5 years and clinical findings at age 5 years. JAMA Ophthalmol. 2014;132(6):676–682. doi: 10.1001/jamaophthalmol.2014.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Solebo AL, Russell-Eggitt I, Cumberland PM, Rahi JS. Risks and outcomes associated with primary intraocular lens implantation in children under 2 years of age: the IoLunder2 cohort study. Br J Ophthalmol. 2015;99(11):1471–1476. doi: 10.1136/bjophthalmol-2014-306394. [DOI] [PubMed] [Google Scholar]
  • 6.Colby SL, Ortman JM. Current Population Reports. Washington, DC: U.S. Census Bureau; 2014. Projections of the Size and Composition of the U S Population: 2014 to 2060. [Google Scholar]
  • 7.Lueder GT, Archer SM, Hered RW, et al. Childhood cataracts and other pediatric lens disorders. In: Lueder GT, editor. 2014–2015 Basic and Clinicial Science Course, Section 6: Pediatric Ophthalmology and Strabismus. San Francisco: Americal Academy of Ophthalmology; 2014. pp. 291–292. [Google Scholar]
  • 8.Wilson ME, Jr, Bartholomew LR, Trivedi RH. Pediatric cataract surgery and intraocular lens implantation: practice styles and preferences of the 2001 ASCRS and AAPOS memberships. J Cataract Refract Surg. 2003;29(9):1811–1820. doi: 10.1016/s0886-3350(03)00220-7. [DOI] [PubMed] [Google Scholar]
  • 9.Solebo AL, Russell-Eggitt I, Nischal KK, et al. Cataract surgery and primary intraocular lens implantation in children < or = 2 years old in the UK and Ireland: finding of national surveys. Br J Ophthalmol. 2009;93(11):1495–1498. doi: 10.1136/bjo.2009.160069. [DOI] [PubMed] [Google Scholar]
  • 10.Infant Aphakia Treatment Study Group. The infant aphakia treatment study: design and clinical measures at enrollment. Arch Ophthalmol. 2010;128(1):21–27. doi: 10.1001/archophthalmol.2009.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Plager DA, Kipfer H, Sprunger DT, et al. Refractive change in pediatric pseudophakia: 6-year follow-up. J Cataract Refract Surg. 2002;28(5):810–815. doi: 10.1016/s0886-3350(01)01156-7. [DOI] [PubMed] [Google Scholar]
  • 12.VanderVeen DK, Nizam A, Lynn MJ, et al. Predictability of intraocular lens calculation and early refractive status: the Infant Aphakia Treatment Study. Arch Ophthalmol. 2012;130(3):293–299. doi: 10.1001/archophthalmol.2011.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Plager DA, Lynn MJ, Buckley EG, et al. Complications, adverse events, and additional intraocular surgery 1 year after cataract surgery in the infant Aphakia Treatment Study. Ophthalmology. 2011;118(12):2330–2334. doi: 10.1016/j.ophtha.2011.06.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Solebo AL, Russell-Eggitt I, Rahi JS. Accuracy of routine data on paediatric cataract in the UK compared to active surveillance: lessons from the IOLu2 study. Br J Ophthalmol. 2013;97(6):757–759. doi: 10.1136/bjophthalmol-2012-302679. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1
2
3

RESOURCES